Images of corpses in Ecuador stoked fear of the coronavirus' effect on developing nations. Infections have yet to peak elsewhere in Latin America.

Colorado, Montana and Tennessee are among states to reopen amid coronavirus outbreak.

The CDC has added six new symptoms to its list of signs that a person has been infected with the new coronavirus, including chills and loss of sense of smell.

Antonia Morales has lived in her historic El Paso neighborhood since 1965 and sees no reason to leave now. Until she and a few other holdouts depart, demolition cannot begin.

U.S. intelligence agencies have concluded that the new coronavirus is "not manmade or genetically modified."

Before a single case of coronavirus, President Nayib Bukele placed El Salvador in lockdown and has engaged in other moves that critics say are authoritarian.

Since the sun's UV rays are lethal to the coronavirus, it seems like a safe place to be, right? Wrong. Here's what sunlight can and can't do.

The U.S. death toll from the coronavirus outbreak has surpassed that of 9/11, even the Vietnam War. Here's a look at COVID-19's place in history.

Washington state has a billion pounds of potatoes -- with no destination

When Texas' energy-dependent economy stalled, mass layoffs hit skilled middle-class workers.

A mutation in the novel coronavirus has led to a new strain viewed as more contagious than the virus that emerged from China, according to a new study.

Italy Easing Lockdown

With imports slowing, many African nations are learning the importance of local manufacturing.

A report by the John Lewis group gives a snapshot of what consumers are buying during the pandemic.

Waterstones CEO: How I keep selling books while my bookshops are shut down.

Danny Boyle credits Irrfan Khan with propelling Slumdog Millionaire to Oscar glory.

Watch the timelapse of artist Lionel Stanhope creating his artwork under London's Waterloo Bridge.

The Soundabout Inclusive Choir is helping to overcome the isolation felt by some people with special needs.

The former Coronation Street star has sparked envy with her stunning decor

The Coronation Street star is a volunteer during the coronavirus crisis

The star gave his support to five-year-old Christian Kilduff, who is raising money for the NHS

Rebecca is staying at home during the coronavirus pandemic with her ex Harry Needs and her partner Andrew Parsons

Kelvin Fletcher has taken a leaf out of Paddy McGuinness's book

Soldier Scott Ratcliffe says was screened for COVID-19 as he returned from tour in Afghanistan

The Real Housewives star says lockdown has brought her closer to husband Paddy

The pair shared video of people gathering in the sunshine

COO, Chris Luttrell shares her wealth of information about the current state of fraud, what IDology research is revealing about patron's trust and the forecasted impact of recent privacy legislation on consumers and businesses.

Keep on reading: Quick Answers to Quick Questions: In Conversation with Chris Luttrell, COO, IDology

ZOLL Medical, a part of the Asahi Kasei Group, won EU clearance for its SuperSaturated Oxygen (SSO2) Therapy System to be used to minimize the damage that heart attacks cause within heart muscle. Approved about a year ago in the United States, SSO2 is the only option beyond percutaneous coronary intervention (stenting) that can help […]

Maurits Lugard, a partner, Josefine Sommer, a senior associate, and Anouchka Hoffman, an associate, at Sidley Austin, examines the consequences that come with the delay of the application of EU Medical Devices Regulation by one year.

LoFric Elle – an intermittent catheter with an L-shaped handle – has won the 2020 Red Dot Design Award.

Health news and commentary from around the Web gathered by the ALLMedPage Today staff

For continued prevention of recurrent VTE

BIO’s “What Every State Should Know About Bayh-Dole” Webinar The Biotechnology Industry Organization (BIO) recently hosted a webinar entitled: “What Every State Should Know About Bayh-Dole: Leveraging University Research to Create Jobs and Spur Economic Development Benefits.” The Bayh-Dole Act, enacted in 1980, placed patent ownership of federally funded research at universities in the hands […]

The charity's Centre for Drug Development will sponsor and fund a future Phase I clinical trial for CB213

More than 6,000 visors have already been delivered to Charing Cross Hospital

Dr Mike England joins as medical director for UK & ROI

Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Ways and Means Chairman Richard E. Neal (D-MA) sent a letter to Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma today raising a series of concerns over the methodology used to distribute and the lack of transparency into how COVID-19 relief funds and loans for health care providers are being spent.  “We write to raise serious concerns about the Provider Relief Fund and the Accelerated and Advance Payment Programs,” Pallone and Neal wrote.  “With respect to each, we are concerned about the lack of transparency with Congress and the American people about how funds are being spent or loans are being made.  We also have grave concerns regarding the methodology being used to distribute $175 billion Congress appropriated for the Provider Relief Fund.” The Chairmen’s letter documents concerns with how the programs are being run, in particular the Administration’s methodologies for distributing funding that has shortchanged a number of critical providers and makes clear that more transparency is needed for Congress to accurately assess the ongoing needs of health care providers as the COVID-19 crisis unfolds. “The Administration’s efforts to establish the Provider Relief Fund to date has been at best, a series of missteps, and at worst, a disregard of Congress’ intent for the program,” Pallone and Neal continued in their letter. Pallone and Neal wrote that when Congress passed the CARES Act, it was clear that the funding provided to HHS for the Provider Relief Fund was for the express purpose, “to prevent, prepare for, and respond to coronavirus.”  The two Chairs voiced concern that some of the funding formulas adopted to date fail to target funding based on the statutory framework relating to COVID-19 driven costs.  In fact, the Chairs write that the level of funding appears to be, “completely disconnected from need.” The Chairmen requested an immediate response from HHS regarding documents and information pertaining to the Provider Relief Fund and the Accelerated and Advanced Payment Program.  Pallone and Neal also wrote that if HHS is unable to immediately provide the information, it should provide a timeline of when the Committees would receive the requested information. While recognizing the incredible demands on the Department at this difficult time, the Chairmen emphasized that, “This crisis demands that we work swiftly and based on the best data available.  Currently, despite repeated requests, this Administration has prevented Congress from obtaining the data that the Department has available on funding for our health care system, data that is necessary to inform near future legislation.  We look forward to receiving this information so that we can conduct the business the American people expect of us.  We look forward to having you join us at the earliest possible date in each of our Committees to discuss these and other COVID-related issues.” To read the full letter, click HERE. ###

Gilead has said that Dr John McHutchison is stepping down after nine years at the firm.

Gilead’s Chief Scientific Officer and Head of Research and Development has decided to leave the company next month, Gilead said.

Under McHutchinson, Gilead developed five new hepatitis drugs, which have been used by as many as 3.2 million people around the world.

read more

Dr Reshma Kewalramani has been made the new Vertex CEO.

Vertex’s Chief Medical Officer Dr Kewalramani will succeed current CEO Jeffrey Leiden who has is now stepping aside from the role after seven years as Chief executive at the Boston-based firm. In stepping down Leiden will serve as executive chairman until the first quarter of 2023.     

Fourty-six year old Dr Kewalramani, who has been at Vertex since 2017, will thus become the first woman to head the firm. Prior to joining Vertex, Kewalramani spent more than 12 years at Amgen.

read more

AbbVie’s former Vice President of Oncology has moved to Ayala Pharmaceuticals to work as its new Chief Medical Officer (CMO). 

Israel-based startup Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers – it is currently working on the development of its pan-Notch inhibitor AL101, currently in Phase 2 in adenoid cystic carcinoma (ACC).

read more

Chief Executive of Gulf Pharmaceutical Industries, Jerome Carle, is stepping down from his post at the United Arab Emirates drug manufacturer facing mounting pressure.

Julphar, one of the biggest generic drugs manufacturers in the Middle East and North Africa said Jerome Carle has “tendered his resignation” and the board has accepted it. His last working day will be December 8th.

read more

Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research investment in the UK, has announced he is to retire for the role next year.

The decision to leave the organisation in 2020 will mark the end of a three-year tenure at its helm, beginning in 2017 when Walport was appointed to “create a single, ambitious organisation and provide the UK with a world class funding system to keep it at the forefront of global research and innovation”.

read more

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs to address the global crisis caused by antimicrobial resistance (AMR), has announced that after 18 years on the board, Joe Eagle is to step down with immediate effect.

Eagle has been instrumental in the financing and strategic direction of Destiny as a private company and brought his expertise for its lead candidate, XF-73 for the prevention of post-surgical infections. A search for a replacement is underway.

read more

Neuronetics, Inc and Chris Thatcher, the President and CEO, have mutually agreed that he will step down from his positions in the company. He will provide transition services and advice to the company until 1 May 2020.

read more

The pharmaceutical analysis firm is continuing its contract analytical laboratory services running, with changes designed to keep people and products safe.

The company has incorporated electronic trial master file document storage capabilities to its Engility clinical trial management platform.